Biocatalytic synthesis of 3,4,5,3′,5′-pentahydroxy-trans-stilbene from piceatannol by two-component flavin-dependent monooxygenase HpaBC

References

• Fulda S. Resveratrol and derivatives for the prevention and treatment of cancer. Drug Discov. Today. 2010;15:757–765.10.1016/j.drudis.2010.07.005
   PubMed Web of Science ®Google Scholar
• Kang NJ, Shin SH, Lee HJ, Lee KW. Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis. Pharmacol. Ther. 2011;130:310–324.10.1016/j.pharmthera.2011.02.004
   PubMed Web of Science ®Google Scholar
• Murias M, Jäger W, Handler N, et al. Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochem. Pharmacol. 2005;69:903–912.10.1016/j.bcp.2004.12.001
   PubMed Web of Science ®Google Scholar
• Baur JA, Pearson kJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337–342.10.1038/nature05354
   PubMed Web of Science ®Google Scholar
• Bhullar KS, Hubbard BP. Lifespan and healthspan extension by resveratrol. Biochim. Biophys. Acta. 2015;1852:1209–1218.10.1016/j.bbadis.2015.01.012
   PubMed Web of Science ®Google Scholar
• Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006;127:1109–1122.10.1016/j.cell.2006.11.013
   PubMed Web of Science ®Google Scholar
• Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275:218–220.10.1126/science.275.5297.218
   PubMed Web of Science ®Google Scholar
• Singh CK, Ndiaye MA, Ahmad N. Resveratrol and cancer: challenges for clinical translation. Biochim. Biophys. Acta. 2015;1852:1178–1185.10.1016/j.bbadis.2014.11.004
   PubMed Web of Science ®Google Scholar
• Smoliga JM, Baur JA, Hausenblas HA. Resveratrol and health – a comprehensive review of human clinical trials. Mol. Nutr. Food Res. 2011;55:1129–1141.10.1002/mnfr.v55.8
   PubMed Web of Science ®Google Scholar
• Kawakami S, Kinoshita Y, Maruki-Uchida H, Yanae K, Sai M, Ito T. Piceatannol and its metabolite, isorhapontigenin, induce SIRT1 expression in THP-1 human monocytic cell line. Nutrients. 2014;6:4794–4804.10.3390/nu6114794
   PubMed Web of Science ®Google Scholar
• Piotrowska H, Kucinska M, Murias M. Biological activity of piceatannol: leaving the shadow of resveratrol. Mutat. Res. 2012;750:60–82.10.1016/j.mrrev.2011.11.001
   PubMed Web of Science ®Google Scholar
• Tang YL, Chan SW. A review of the pharmacological effects of piceatannol on cardiovascular diseases. Phytother. Res. 2014;28:1581–1588.10.1002/ptr.5185
   PubMed Web of Science ®Google Scholar
• Matsui Y, Sugiyama K, Kamei M, et al. Extract of passion fruit (Passiflora edulis) seed containing high amounts of piceatannol inhibits melanogenesis and promotes collagen synthesis. J. Agric. Food Chem. 2010;58:11112–11118.10.1021/jf102650d
   PubMed Web of Science ®Google Scholar
• Sano S, Sugiyama K, Ito T, Katano Y, Ishihata A. Identification of the strong vasorelaxing substance scirpusin B, a dimer of piceatannol, from passion fruit (Passiflora edulis) seeds. J. Agric. Food Chem. 2011;59:6209–6213.10.1021/jf104959t
   PubMed Web of Science ®Google Scholar
• Kim DH, Ahn T, Jung HC, Pan JG, Yun CH. Generation of the human metabolite piceatannol from the anticancer-preventive agent resveratrol by bacterial cytochrome P450 BM3. Drug Metab. Dispos. 2009;37:932–936.10.1124/dmd.108.026484
   PubMed Web of Science ®Google Scholar
• Lee N, Kim EJ, Kim BG. Regioselective hydroxylation of trans-resveratrol via inhibition of tyrosinase from Streptomyces avermitilis MA4680. ACS Chem. Biol. 2012;7:1687–1692.10.1021/cb300222b
   PubMed Web of Science ®Google Scholar
• Furuya T, Kino K. Catalytic activity of the two-component flavin-dependent monooxygenase from Pseudomonas aeruginosa toward cinnamic acid derivatives. Appl. Microbiol. Biotechnol. 2014;98:1145–1154.10.1007/s00253-013-4958-y
   PubMed Web of Science ®Google Scholar
• Furuya T, Kino K. Regioselective synthesis of piceatannol from resveratrol: catalysis by two-component flavin-dependent monooxygenase HpaBC in whole cells. Tetrahedron Lett. 2014;55:2853–2855.10.1016/j.tetlet.2014.03.076
   Web of Science ®Google Scholar
• Chakraborty S, Ortiz-Maldonado M, Entsch B, Ballou DP. Studies on the mechanism of p-hydroxyphenylacetate 3-hydroxylase from Pseudomonas aeruginosa: a system composed of a small flavin reductase and a large flavin-dependent oxygenase. Biochemistry. 2010;49:372–385.10.1021/bi901454u
   PubMed Web of Science ®Google Scholar
• Ellis HR. The FMN-dependent two-component monooxygenase systems. Arch. Biochem. Biophys. 2010;497:1–12.10.1016/j.abb.2010.02.007
   PubMed Web of Science ®Google Scholar
• Galan B, Diaz E, Prieto MA, Garcia JL. Functional analysis of the small component of the 4-hydroxyphenylacetate 3-monooxygenase of Escherichia coli W: a prototype of a new flavin:NAD(P)H reductase subfamily. J. Bacteriol. 2000;182:627–636.10.1128/JB.182.3.627-636.2000
   PubMed Web of Science ®Google Scholar
• Lin Y, Yan Y. Biotechnological production of plant-specific hydroxylated phenylpropanoids. Biotechnol. Bioeng. 2014;111:1895–1899.10.1002/bit.25237
   PubMed Web of Science ®Google Scholar
• Furuya T, Kino K. Discovery of 2-naphthoic acid monooxygenases by genome mining and their use as biocatalysts. ChemSusChem. 2009;2:645–649.10.1002/cssc.v2:7
   PubMed Web of Science ®Google Scholar
• Murias M, Handler N, Erker T, et al. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg. Med. Chem. 2004;12:5571–5578.10.1016/j.bmc.2004.08.008
   PubMed Web of Science ®Google Scholar
• Lam SH, Chen JM, Kang CJ, Chen CH, Lee SS. α-Glucosidase inhibitors from the seeds of Syagrus romanzoffiana. Phytochemistry. 2008;69:1173–1178.10.1016/j.phytochem.2007.12.004
   PubMed Web of Science ®Google Scholar
• Li H, Wu WK, Zheng Z, et al. 3,3′,4,5,5′-Pentahydroxy-trans-stilbene, a resveratrol derivative, induces apoptosis in colorectal carcinoma cells via oxidative stress. Eur. J. Pharmacol. 2010;637:55–61.10.1016/j.ejphar.2010.04.009
   PubMed Web of Science ®Google Scholar
• Lee KW, Kang NJ, Rogozin EA, et al. The resveratrol analogue 3,5,3′,4′,5′-pentahydroxy-trans-stilbene inhibits cell transformation via MEK. Int. J. Cancer. 2008;123:2487–2496.10.1002/ijc.v123:11
   PubMed Web of Science ®Google Scholar